Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada
Authors
Salmaan Kanji (ORCID: https://orcid.org/0000-0003-0594-0360)
Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada
Salmaan Kanji, Mary-Anne Doyle, D. William Cameron, Bashour Yazji et al.
Journal
BMJ Open
Topics
HIV/AIDS drug development and treatment
article
Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada
Salmaan Kanji, Mary-Anne Doyle, D. William Cameron, Bashour Yazji, L. Hermida Porto, Nancy Tremblay, Zhang Guijin
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(7)
Institutions
University of Ottawa (CA), Ottawa Hospital (CA), Ottawa Hospital Research Institute (CA)